Which has grown faster, KYNB or NSPR?

Over the past five years, NSPR grew revenue faster — KYNB at a -51.49% CAGR versus NSPR at 27.79%.

Is KYNB or NSPR more profitable?

KYNB runs the higher net margin — KYNB at 3967.77% versus NSPR at -355.17%.

How have KYNB and NSPR total returns compared?

Over the past 10 years, KYNB delivered -35.88% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

Kyntra Bio, Inc. (KYNB) vs InspireMD, Inc. (NSPR)

A side-by-side comparison of Kyntra Bio, Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KYNB

Kyntra Bio, Inc.

$24M

$5.95HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT

NSPR

InspireMD, Inc.

$28M

$0.60HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT

Total return — KYNB vs NSPR

growth of $100 · dividends reinvested · last 10y

KYNB -98.8% (-35.8%/yr)NSPR -100.0% (-68.2%/yr)KYNB compounded faster over this window

Log scale — wide-divergence pair

KYNB NSPR

KYNB vs NSPR: by the numbers

•NSPR is the larger company ($28M vs $24M market cap).
•KYNB is profitable (3967.77% net margin) while NSPR runs a net loss (-355.17%).
•NSPR grew revenue faster over the past five years (27.79% vs -51.49% CAGR).

Metrics side by side

Valuation

Metric	KYNB	NSPR
P/S ratio	5.22	2.59
P/B ratio	N/A	0.89

Profitability

Metric	KYNB	NSPR
Gross margin	91.37%	29.50%
Operating margin	-712.66%	-546.97%
Net margin	3967.77%	-355.17%
ROE	N/A	-122.19%
ROIC	-78.16%	-153.04%

Growth (annualized)

Metric	KYNB	NSPR
Revenue CAGR (5Y)	-51.49%	27.79%
Total return CAGR (5Y)	-52.67%	-36.91%

Frequently asked

Which has grown faster, KYNB or NSPR?: Over the past five years, NSPR grew revenue faster — KYNB at a -51.49% CAGR versus NSPR at 27.79%.
Is KYNB or NSPR more profitable?: KYNB runs the higher net margin — KYNB at 3967.77% versus NSPR at -355.17%.
How have KYNB and NSPR total returns compared?: Over the past 10 years, KYNB delivered -35.88% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KYNB analysis Full NSPR analysis Interactive comparison tool

Dig into the metrics

Kyntra Bio ROE InspireMD ROE Kyntra Bio operating margin InspireMD operating margin Kyntra Bio revenue growth InspireMD revenue growth Kyntra Bio free cash flow InspireMD free cash flow

Kyntra Bio & InspireMD appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.